Argent BioPharma Ltd (RGTLF)

Currency in USD
0.059
0.000(0.00%)
Closed·

RGTLF Financial Summary

Key Ratios

P/E Ratio-0.2
Price/Book-0.44
Debt / Equity-85.95%
Return on Equity443.03%
Dividend Yield0.00%
EBITDA-16.97M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2015
30/06
2016
30/06
2017
30/06
2018
30/06
2019
30/06
2020
30/06
2021
30/06
2022
30/06
2023
30/06
2024
30/06
* In Millions of AUD (except for per share items)

Earnings

Latest Release
Feb 28, 2025
EPS / Forecast
-0.24 / --
Revenue / Forecast
4.28K / --
EPS Revisions
Last 90 days

FAQ

What were Argent BioPharma Ltd's earnings for the latest quarter?

The Argent BioPharma Ltd EPS (TTM) is -0.45. Argent BioPharma Ltd reported sales of 0.00, net income of -12.16, and EPS of -0.24 for the latest quarter.

What was Argent BioPharma Ltd's net income for the latest quarter?

Argent BioPharma Ltd's net income for the latest quarter was -12.16.

How did Argent BioPharma Ltd's performance compare year-over-year in the latest quarter?

The company's revenue moved from 0.29 in the previous quarter to 0.00 in the latest quarter, and net income moved from -10.45 to -12.16 compared to the previous quarter.

What is Argent BioPharma Ltd's net profit margin on a TTM basis?

Argent BioPharma Ltd's trailing twelve months (TTM) net profit margin is -1,967.34%.

How does Argent BioPharma Ltd's debt to equity ratio compare to industry standards?

Argent BioPharma Ltd's total debt-to-equity ratio is -85.95%.

What is Argent BioPharma Ltd's return on investment on a TTM basis?

Argent BioPharma Ltd's trailing twelve months (TTM) return on investment (ROI) is 443.03%.

Did Argent BioPharma Ltd gain or lose cash last quarter?

In the latest quarter, Argent BioPharma Ltd's net change in cash was 0.02 million.

What were Argent BioPharma Ltd's total assets and liabilities in the latest quarter?

As of the latest quarter, Argent BioPharma Ltd reported total assets of 3.06 million and total liabilities of 13.19 million.

How has Argent BioPharma Ltd's total revenue grown this year?

Argent BioPharma Ltd's total revenue was 0.29 in the previous quarter and 0.00 in the latest quarter.

What is Argent BioPharma Ltd's gross margin on a TTM basis?

Argent BioPharma Ltd's trailing twelve months (TTM) gross margin is -127.08%.

What was Argent BioPharma Ltd's revenue per share for the latest quarter?

Argent BioPharma Ltd's revenue per share for the latest quarter was 43.95.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.